The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Epstein-Barr Virus Entry
Open accessAbstract
One of the many conundrums of herpesvirology is why a herpesvirus is so profligate in its use of four or more envelope glycoproteins for entry into a cell when other viruses can manage very well with only one or two. Profligacy does, however, have its advantages. Epstein-Barr virus (EBV), originally
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA
Epstein, M. A., Achong, B. G., & Barr, Y. M. (1964) · The Lancet · doi:10.1016/s0140-6736(64)91524-7 · Cited by 2,778
Rickinson, A. (2001) · Virus Research · doi:10.1016/s0168-1702(01)00436-1 · Cited by 2,179
DNA sequence and expression of the B95-8 Epstein—Barr virus genome
Baer, R., Bankier, A. T., Biggin, M. D., Deininger, P. L., Farrell, P. J., Gibson, T. J., Hatfull, G., Hudson, G. S., Satchwell, S. C., Séguin, C., et al. (1984) · Nature · doi:10.1038/310207a0 · Cited by 2,053
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
Russo, J. J., Bohenzky, R. A., Chien, M.-C., Chen, J., Yan, M., Maddalena, D., Parry, J. P., Peruzzi, D., Edelman, I. S., Chang, Y., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14862 · Cited by 1,467
Weisman, H. F., Bartow, T., Leppo, M. K., Marsh, H. C., Carson, G. R., Concino, M. F., Boyle, M. P., Roux, K. H., Weisfeldt, M. L., & Fearon, D. T. (1990) · Science · doi:10.1126/science.2371562 · Cited by 977
Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.
Fingeroth, J. D., Weis, J. J., Tedder, T. F., Strominger, J. L., Biro, P. A., & Fearon, D. T. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.14.4510 · Cited by 939
Assembly, Transport, and Function of MHC Class II Molecules
Cresswell, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.259 · Cited by 807
Spear, P. G., & Longnecker, R. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10179-10185.2003 · Cited by 590 · cited 1×
“Fusion of the EBV envelope with both a B cell and an epithelial cell requires three glycoproteins, gHgL and gB, which are conserved throughout the herpesvirus family and which have been referred to as the core fusion machinery (55).”
BackgroundHerold, B. C., WuDunn, D., Soltys, N., & Spear, P. G. (1991) · Journal of Virology · doi:10.1128/jvi.65.3.1090-1098.1991 · Cited by 572
Virus membrane-fusion proteins: more than one way to make a hairpin
Kielian, M., & Rey, F. A. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1326 · Cited by 570
Crystal Structure of Glycoprotein B from Herpes Simplex Virus 1
Heldwein, E. E., Lou, H., Bender, F. C., Cohen, G. H., Eisenberg, R. J., & Harrison, S. C. (2006) · Science · doi:10.1126/science.1126548 · Cited by 562
Laichalk, L. L., & Thorley-Lawson, D. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1296-1307.2005 · Cited by 538
Tanner, J., Weis, J., Fearon, D., Whang, Y., & Kieff, E. (1987) · Cell · doi:10.1016/0092-8674(87)90216-9 · Cited by 505
Alternate replication in B cells and epithelial cells switches tropism of Epstein–Barr virus
Borza, C. M., & Hutt-Fletcher, L. M. (2002) · Nature Medicine · doi:10.1038/nm0602-594 · Cited by 484
Self-citationRole of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion
Cai, W. H., Gu, B., & Person, S. (1988) · Journal of Virology · doi:10.1128/jvi.62.8.2596-2604.1988 · Cited by 476
The CD19/CR2/TAPA-1 Complex of B Lymphocytes: Linking Natural To Acquired Immunity
Fearon, D. T. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.127 · Cited by 474
Proteins of purified Epstein-Barr virus
Johannsen, E., Luftig, M., Chase, M. R., Weicksel, S., Cahir-McFarland, E., Illanes, D., Sarracino, D., & Kieff, E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407320101 · Cited by 450
Crystal Structure of the Low-pH Form of the Vesicular Stomatitis Virus Glycoprotein G
Roche, S., Bressanelli, S., Rey, F. A., & Gaudin, Y. (2006) · Science · doi:10.1126/science.1127683 · Cited by 435
Herpes Simplex Virus Glycoprotein D Bound to the Human Receptor HveA
Carfı́, A., Willis, S. H., Whitbeck, J. C., Krummenacher, C., Cohen, G. H., Eisenberg, R. J., & Wiley, D. C. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00298-2 · Cited by 391
Structure of the Prefusion Form of the Vesicular Stomatitis Virus Glycoprotein G
Roche, S., Rey, F. A., Gaudin, Y., & Bressanelli, S. (2007) · Science · doi:10.1126/science.1135710 · Cited by 364
Nemerow, G. R., Wolfert, R., McNaughton, M. E., & Cooper, N. R. (1985) · Journal of Virology · doi:10.1128/jvi.55.2.347-351.1985 · Cited by 344
Natarajan, K., Dimasi, N., Wang, J., Mariuzza, R. A., & Margulies, D. H. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064812 · Cited by 335
Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes
Li, Q., Spriggs, M. K., Kovats, S., Turk, S. M., Comeau, M. R., Nepom, B., & Hutt-Fletcher, L. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4657-4662.1997 · Cited by 319
Self-citationEpstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells
Tugizov, S. M., Berline, J. W., & Palefsky, J. M. (2003) · Nature Medicine · doi:10.1038/nm830 · Cited by 286
Pertel, P. E., Fridberg, A., Parish, M. L., & Spear, P. G. (2001) · Virology · doi:10.1006/viro.2000.0713 · Cited by 285
Molesworth, S. J., Lake, C. M., Borza, C. M., Turk, S. M., & Hutt-Fletcher, L. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.14.6324-6332.2000 · Cited by 281
Self-citationA Children's Cancer Dependent on Climatic Factors
BURKITT, D. (1962) · Nature · doi:10.1038/194232a0 · Cited by 267
Structure of unliganded HSV gD reveals a mechanism for receptor‐mediated activation of virus entry
Krummenacher, C., Supekar, V. M., Whitbeck, J. C., Lazear, E., Connolly, S. A., Eisenberg, R. J., Cohen, G. H., Wiley, D. C., & Carfí, A. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600875 · Cited by 265
Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand
Tormo, J., Natarajan, K., Margulies, D. H., & Mariuzza, R. A. (1999) · Nature · doi:10.1038/45170 · Cited by 255
Epstein–Barr virus infection and replication in a human epithelial cell system
Li, Q. X., Young, L. S., Niedobitek, G., Dawson, C. W., Birkenbach, M., Wang, F., & Rickinson, A. B. (1992) · Nature · doi:10.1038/356347a0 · Cited by 226
Immunoglobulin A-Induced Shift of Epstein-Barr Virus Tissue Tropism
Sixbey, J. W., & Yao, Q.-Y. (1992) · Science · doi:10.1126/science.1312750 · Cited by 221
Resting B cells as a transfer vehicle for Epstein–Barr virus infection of epithelial cells
Shannon-Lowe, C. D., Neuhierl, B., Baldwin, G., Rickinson, A. B., & Delecluse, H.-J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510512103 · Cited by 206
gp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptor.
Frade, R., Barel, M., Ehlin-Henriksson, B., & Klein, G. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.5.1490 · Cited by 194
Bzik, D. J., Fox, B. A., Deluca, N. A., & Person, S. (1984) · Virology · doi:10.1016/0042-6822(84)90022-9 · Cited by 186
Subramanian, R. P., & Geraghty, R. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608374104 · Cited by 180
Wang, X., Kenyon, W. J., Li, Q., Müllberg, J., & Hutt-Fletcher, L. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.7.5552-5558.1998 · Cited by 180
Self-citationJanz, A., Oezel, M., Kurzeder, C., Mautner, J., Pich, D., Kost, M., Hammerschmidt, W., & Delecluse, H.-J. (2000) · Journal of Virology · doi:10.1128/jvi.74.21.10142-10152.2000 · Cited by 172
Epstein-Barr virus enters B cells and epithelial cells by different routes
Miller, N., & Hutt-Fletcher, L. M. (1992) · Journal of Virology · doi:10.1128/jvi.66.6.3409-3414.1992 · Cited by 167
Self-citationCai, W. Z., Person, S., Warner, S. C., Zhou, J. H., & DeLuca, N. A. (1987) · Journal of Virology · doi:10.1128/jvi.61.3.714-721.1987 · Cited by 166
Structure of the Epstein-Barr Virus gp42 Protein Bound to the MHC Class II Receptor HLA-DR1
Mullen, M. M., Haan, K. M., Longnecker, R., & Jardetzky, T. S. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00465-3 · Cited by 164
Muggeridge, M. I. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-8-2017 · Cited by 160
Nemerow, G. R., & Cooper, N. R. (1984) · Virology · doi:10.1016/0042-6822(84)90102-8 · Cited by 159
Sharma-Walia, N., Naranatt, P. P., Krishnan, H. H., Zeng, L., & Chandran, B. (2004) · Journal of Virology · doi:10.1128/jvi.78.8.4207-4223.2004 · Cited by 156
Pseudorabies Virus Glycoprotein M Inhibits Membrane Fusion
Klupp, B. G., Nixdorf, R., & Mettenleiter, T. C. (2000) · Journal of Virology · doi:10.1128/jvi.74.15.6760-6768.2000 · Cited by 151
Jardetzky, T. S., & Lamb, R. A. (2004) · Nature · doi:10.1038/427307a · Cited by 150
Brack, A. R., Dijkstra, J. M., Granzow, H., Klupp, B. G., & Mettenleiter, T. C. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5364-5372.1999 · Cited by 146
Epstein-Barr Virus Lacking Glycoprotein gp42 Can Bind to B Cells but Is Not Able To Infect
Wang, X., & Hutt‐Fletcher, L. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.158-163.1998 · Cited by 145
Self-citationTanner, J. E., Whang, Y. E., Sample, J. T., et al. (1988) · Journal of Virology · doi:10.1128/jvi.62.12.4452-4464.1988 · Cited by 139
Spriggs, M. K., Armitage, R. J., Comeau, M. R., et al. (1996) · Journal of Virology · doi:10.1128/jvi.70.8.5557-5563.1996 · Cited by 135
Infection of Primary Human Monocytes by Epstein-Barr Virus
Savard, M., Bélanger, C., Tardif, M. R., Gourde, P., Flamand, L., & Gosselin, J. (2000) · Journal of Virology · doi:10.1128/jvi.74.6.2612-2619.2000 · Cited by 135
Pyles, R. B., Sawtell, N. M., & Thompson, R. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6706-6713.1992 · Cited by 134
Haan, K. M., Lee, S. K., & Longnecker, R. (2001) · Virology · doi:10.1006/viro.2001.1141 · Cited by 134
Human Herpesvirus 8 Glycoprotein B (gB), gH, and gL Can Mediate Cell Fusion
Pertel, P. E. (2002) · Journal of Virology · doi:10.1128/jvi.76.9.4390-4400.2002 · Cited by 128
A monoclonal antibody to glycoprotein gp85 inhibits fusion but not attachment of Epstein-Barr virus
Miller, N., & Hutt‐Fletcher, L. M. (1988) · Journal of Virology · doi:10.1128/jvi.62.7.2366-2372.1988 · Cited by 125
Self-citationConnolly, S. A., Landsburg, D. J., Carfı́, A., Wiley, D. C., Cohen, G. H., & Eisenberg, R. J. (2003) · Journal of Virology · doi:10.1128/jvi.77.14.8127-8140.2003 · Cited by 121
Structure of the Epstein-Barr virus major envelope glycoprotein
Szakonyi, G., Klein, M. G., Hannan, J. P., Young, K. A., Ma, R. Z., Asokan, R., Holers, V. M., & Chen, X. S. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1161 · Cited by 119
Gage, P. J., Levine, M., & Glorioso, J. C. (1993) · Journal of Virology · doi:10.1128/jvi.67.4.2191-2201.1993 · Cited by 112
Rivailler, P., Cho, Y.-G., & Wang, F. (2002) · Journal of Virology · doi:10.1128/jvi.76.23.12055-12068.2002 · Cited by 112
Ressing, M. E., van Leeuwen, D., Verreck, F. A. W., Gomez, R., Heemskerk, B., Toebes, M., Mullen, M. M., Jardetzky, T. S., Longnecker, R., Schilham, M. W., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2034960100 · Cited by 111
Self-citationIntracellular trafficking of two major Epstein-Barr virus glycoproteins, gp350/220 and gp110
Gong, M., & Kieff, E. (1990) · Journal of Virology · doi:10.1128/jvi.64.4.1507-1516.1990 · Cited by 110
Chang, Y., Tung, C., Huang, Y.-T., Lu, J., Chen, J., & Tsai, C.-H. A. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8857-8866.1999 · Cited by 106
Connolly, S. A., Landsburg, D. J., Carfı́, A., Wiley, D. C., Eisenberg, R. J., & Cohen, G. H. (2002) · Journal of Virology · doi:10.1128/jvi.76.21.10894-10904.2002 · Cited by 104
Ressing, M. E., van Leeuwen, D., Verreck, F. A. W., Keating, S. E., Gomez, R., Franken, K. L. M. C., Ottenhoff, T. H. M., Spriggs, M. K., Schumacher, T. N., Hutt‐Fletcher, L. M., et al. (2004) · Journal of Virology · doi:10.1128/jvi.79.2.841-852.2005 · Cited by 103
Self-citationLambris, J. D., Ganu, V., Hirani, S., & Müller‐Eberhard, H. J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4235 · Cited by 95
Epstein-Barr Virus Binding to CD21 Activates the Initial Viral Promoter via NF-κB Induction
Sugano, N., Chen, W., Roberts, M. L., & Cooper, N. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.5.731 · Cited by 94
Gan, Y. J., Chodosh, J., Morgan, A. J., & Sixbey, J. W. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.519-526.1997 · Cited by 94
Duus, K., Hatfield, C. C., & Grose, C. F. (1995) · Virology · doi:10.1006/viro.1995.1359 · Cited by 93
Kirschner, A. N., Omerović, J., Popov, B. V., Longnecker, R., & Jardetzky, T. S. (2006) · Journal of Virology · doi:10.1128/jvi.00572-06 · Cited by 91
The crystal structure of human CD21: Implications for Epstein–Barr virus and C3d binding
Prota, A. E., Sage, D. R., Stehle, T., & Fingeroth, J. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162360499 · Cited by 82
McShane, M. P., & Longnecker, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404535101 · Cited by 81
Baghian, A., Huang, L.-Y. M., Newman, S., Jayachandra, S., & Kousoulas, K. G. (1993) · Journal of Virology · doi:10.1128/jvi.67.4.2396-2401.1993 · Cited by 79
Krishnan, H. H., Sharma-Walia, N., Zeng, L., Gao, S., & Chandran, B. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.10952-10967.2005 · Cited by 71
Foster, T. P., Melancon, J. M., & Kousoulas, K. G. (2001) · Virology · doi:10.1006/viro.2001.1004 · Cited by 70
Omerović, J., Lev, L., & Longnecker, R. (2005) · Journal of Virology · doi:10.1128/jvi.79.19.12408-12415.2005 · Cited by 68
Epstein-Barr Virus Shed in Saliva Is High in B-Cell-Tropic Glycoprotein gp42
Jiang, R., Scott, R. S., & Hutt‐Fletcher, L. M. (2006) · Journal of Virology · doi:10.1128/jvi.00497-06 · Cited by 65
Self-citationKirschner, A. N., Lowrey, A. S., Longnecker, R., & Jardetzky, T. S. (2007) · Journal of Virology · doi:10.1128/jvi.00575-07 · Cited by 61
Antibodies to gp350/220 Enhance the Ability of Epstein-Barr Virus To Infect Epithelial Cells
Turk, S. M., Jiang, R., Chesnokova, L. S., & Hutt‐Fletcher, L. M. (2006) · Journal of Virology · doi:10.1128/jvi.00622-06 · Cited by 59
Self-citationComplement receptors and the shaping of the natural antibody repertoire
Holers, V. M. (2004) · Springer Seminars in Immunopathology · doi:10.1007/s00281-004-0186-y · Cited by 58
Coreceptor restriction within the HLA-DQ locus for Epstein–Barr virus infection
Haan, K. M., & Longnecker, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160171697 · Cited by 58
Tanner, J. E., Alfieri, C., Chatila, T. A., & Díaz‐Mitoma, F. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.570-575.1996 · Cited by 58
D’Addario, M., Libermann, T. A., Xu, J., Ahmad, A., & Menézes, J. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4589 · Cited by 57
Guerreiro‐Cacais, A. O., Li, L., Donati, D., Bejarano, M. T., Morgan, A. J., Masucci, M. G., Hutt‐Fletcher, L. M., & Levitsky, V. (2004) · Journal of General Virology · doi:10.1099/vir.0.80140-0 · Cited by 57
Self-citationWu, L., Borza, C. M., & Hutt‐Fletcher, L. M. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.10923-10930.2005 · Cited by 53
Self-citationSinclair, A. J., & Farrell, P. J. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5461-5468.1995 · Cited by 52
Characterization of the Epstein–Barr virus glycoprotein BMRF-2
Xiao, J., Palefsky, J. M., Herrera, R., & Tugizov, S. M. (2006) · Virology · doi:10.1016/j.virol.2006.09.047 · Cited by 49
Kopp, A., Blewett, E. L., Misra, V., & Mettenleiter, T. C. (1994) · Journal of Virology · doi:10.1128/jvi.68.3.1667-1674.1994 · Cited by 48
Borza, C. M., & Hutt‐Fletcher, L. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.9.7577-7582.1998 · Cited by 48
Self-citationSilva, A. L., Omerović, J., Jardetzky, T. S., & Longnecker, R. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5946-5956.2004 · Cited by 47
Strive, T., Borst, E. M., Messerle, M., & Radsak, K. (2002) · Journal of Virology · doi:10.1128/jvi.76.3.1252-1264.2002 · Cited by 42
Point mutations in EBV gH that abrogate or differentially affect B cell and epithelial cell fusion
Wu, L., & Hutt‐Fletcher, L. M. (2007) · Virology · doi:10.1016/j.virol.2007.01.025 · Cited by 38
Self-citationViral Glycoproteins and an Evolutionary Conundrum
Steven, A. C., & Spear, P. G. (2006) · Science · doi:10.1126/science.1129761 · Cited by 34
Mutational Analysis of the HLA Class II Interaction with Epstein-Barr Virus Glycoprotein 42
McShane, M. P., Mullen, M. M., Haan, K. M., Jardetzky, T. S., & Longnecker, R. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7655-7662.2003 · Cited by 28
Gill, M. B., Roecklein‐Canfield, J. A., Sage, D. R., Zambela-Soediono, M., Longtine, N., Uknis, M. E., & Fingeroth, J. D. (2004) · Journal of Cell Science · doi:10.1242/jcs.01113 · Cited by 27
Lee, S. K. (1999) · Virology · doi:10.1006/viro.1999.0012 · Cited by 24
Cited by
Primary Epstein-Barr virus infection
Dunmire, S. K., Verghese, P. S., & Balfour, H. H. (2018) · Journal of Clinical Virology · doi:10.1016/j.jcv.2018.03.001 · Cited by 520
Fusing structure and function: a structural view of the herpesvirus entry machinery
Connolly, S. A., Jackson, J. O., Jardetzky, T. S., & Longnecker, R. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2548 · Cited by 477
Epstein-Barr Virus and Systemic Autoimmune Diseases
Houen, G., & Trier, N. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.587380 · Cited by 379
Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site
Kanekiyo, M., Bu, W., Joyce, M. G., Meng, G., Whittle, J. R. R., Baxa, U., Yamamoto, T., Narpala, S., Todd, J.-P., Rao, S. S., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.043 · Cited by 366
The structural basis of herpesvirus entry
Connolly, S. A., Jardetzky, T. S., & Longnecker, R. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00448-w · Cited by 360
Metadata
- Authors
- Hutt-Fletcher, L. M.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2007-08
- Volume
- 81
- Issue
- 15
- Pages
- 7825-7832
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2114890741
- Cited by
- 323
- References
- 94
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.